Genes and signals controlling mammalian hematopoiesis.

控制哺乳动物造血的基因和信号。

基本信息

项目摘要

Our studies are focused in three areas. The first involves characterization of the role of T cell antigen receptor (TCR) signals, and in particular, individual TCR signal transducing subunits and signal transducing motifs in T cell development. Second, we have extended our studies to include analysis of signal transducing molecules that function downstream of the TCR or that inhibit TCR signaling. The aim of these studies is to understand how these molecules participate in TCR mediated signaling and to determine what roles they and the signaling pathways they regulate play in T cell maturation and T cell activation. Finally, the lab has initiated a new area of investigation of the genes controlling the generation and maintenance of Hematopoietic Stem Cells. Role of T cell antigen receptor (TCR) signaling in thymocyte development. Signal transduction sequences (termed Immunoreceptor Tyrosine-based Activation Motifs; ITAMs) are contained within four distinct subunits of the multimeric TCR complex (zeta, CD3-gamma, -delta, -epsilon). Di-tyrosine residues within ITAMs are phosphorylated upon TCR engagement and function to recruit signaling molecules, such as protein tyrosine kinases, to the TCR complex, thereby initiating the T cell activation cascade. To determine if TCR signal transducing subunits perform distinct or analogous functions in development, we previously generated zeta deficient and CD3-epsilon deficient mice by gene targeting, genetically reconstituted these mice with transgenes encoding wild-type or signaling-deficient (ITAM-mutant) forms of zeta and CD3-epsilon, and characterized the developmental and functional consequences of these alterations on TCR signaling. The results of these studies demonstrated that TCR-ITAMs are functionally equivalent but act in concert to amplify TCR signals. TCR signal amplification was found to be critical for thymocyte selection, the process by which potentially useful immature T cells are instructed to survive and differentiate further-(positive selection), and potentially auto-reactive cells that may cause auto-immune disease are deleted in the thymus (negative selection). Thus, the multi-subunit structure of the TCR may have evolved to enable complex organisms to develop a broad, self-restricted yet auto-tolerant T cell repertoire. In current studies we are using conditional gene expression systems to analyze the importance of TCR signaling at specific stages of development. In addition, we are using microarray and subtractive cloning to identify genes involved in T cell signaling and T cell development. Signaling molecules that function downstream of the TCR or that function to "fine-tune" the TCR signal. Our results with TCR-ITAM mutant mice suggested that other signaling molecules can compensate for the reduction in TCR signal strength. An initial FACS-based search for candidate compensatory molecules led us to CD5, a TCR associated trans-membrane protein that inhibits TCR signaling. Importantly, we found that CD5 surface expression is regulated by and parallels TCR signal intensity. Thus, rather than simply functioning as a co-receptor, CD5 acts to fine-tune TCR signals during thymocyte selection since its level of surface expression depends upon the intensity of TCR signaling. An obvious benefit of such fine-tuning of the TCR signaling response would be to enable the generation of a T cell repertoire with the maximum possible diversity since it would allow a broader range of TCRs to pass through the signaling window of positive selection. Since little was known about how CD5 regulates TCR signaling, we initiated a project to characterize CD5 function, both genetically and biochemically. The results of these experiments suggest a mechanism for CD5 mediated TCR signal inhibition that we are currently testing experimentally. We have also begun a search for additional tuning molecules using a microarray based screen. The identification of such molecules may have importance for the diagnosis and treatment of human autoimmune diseases. In another study, we identified a novel T-lineage restricted putative adaptor protein, designated Themis. Biochemical studies indicate that Themis functions at a distal point in the TCR signaling pathway and may have an important role is helping to sustain TCR signaling. Themis-/- mice have been generated and their phenotype reveals an important role for this protein in late thymocyte development and selection. Current and projected experiments are directed at elucidating the mechanism by which Themis functions in T cell signaling and development. Genes controlling Hematopoietic Stem cell specification and maintenance. The hematopoietic system is composed of a functionally diverse group of cells that originate from a common hematopoietic stem cell (HSC) capable of long-term self-renewal and multi-lineage differentiation. Self-renewal ensures that a pool of HSCs persists throughout life, whereas differentiation leads to the continuous generation of all circulating blood cells including lymphocytes, myeloid cells, erythrocytes and platelets. We initiated experiments aimed at identifying genes important for HSC generation and maintenance. Our initial studies focused on the role of LIM domain binding protein-1 (Ldb1) in hematopoiesis. The results of these experiments revealed a critical function for Ldb1 in regulating the self-renewal/differentiation cell fate decision in hematopoietic stem cells and suggest that Ldb1 nucleated transcription complexes may control maintenance of lineage specific stem cells. Consistent with this, a genome-wide ChIP-seq screen identified Ldb1 binding sites within the promoter/gene body of a high percentage of genes known to be essential for HSC maintenance. Deletion of Ldb1 also resulted in decreased expression of these genes suggesting that Ldb1 complexes function as "master regulators" of the transcriptional program regulating HSC maintenance/self-renewal.
我们的研究集中在三个领域。 首先涉及表征T细胞抗原受体(TCR)信号的作用,尤其是单个TCR信号转导亚基和信号转导基序在T细胞发育中的作用。 其次,我们扩展了研究,以包括对TCR下游或抑制TCR信号传导的信号转导分子的分析。这些研究的目的是了解这些分子如何参与TCR介导的信号传导,并确定它们在T细胞成熟和T细胞激活中调节发挥作用的信号传导途径。最后,该实验室已开始对控制造血干细胞的产生和维持的基因的新领域。 T细胞抗原受体(TCR)信号传导在胸腺细胞发育中的作用。 信号转导序列(称为免疫受体酪氨酸的活化基序; ITAMS)包含在多聚体TCR复合物的四个不同亚基中(Zeta,CD3 -Gamma,-delta,-epsilon)。 ITAM中的Di-tyrosine残基在TCR参与和功能下被磷酸化,以募集TCR复合物等信号分子,例如蛋白酪氨酸激酶,从而启动T细胞激活级联反应。 To determine if TCR signal transducing subunits perform distinct or analogous functions in development, we previously generated zeta deficient and CD3-epsilon deficient mice by gene targeting, genetically reconstituted these mice with transgenes encoding wild-type or signaling-deficient (ITAM-mutant) forms of zeta and CD3-epsilon, and characterized the developmental and functional consequences of these alterations on TCR信号传导。这些研究的结果表明,TCR-ITAM在功能上是等效的,但协同作用以扩大TCR信号。发现TCR信号扩增对于胸腺细胞选择至关重要,胸腺细胞的选择至关重要,该过程指示潜在有用的不成熟的T细胞生存和分化进一步的(阳性选择),并且可能导致可能引起自身免疫性疾病的潜在自身反应性细胞在胸膜中被删除(阴性选择)。 因此,TCR的多生产结构可能已经发展为使复杂的生物能够发展出宽阔,自限制但自动耐受性的T细胞库。在当前的研究中,我们使用条件基因表达系统来分析特定发育阶段的TCR信号传导的重要性。此外,我们正在使用微阵列和减法克隆来识别与T细胞信号传导和T细胞发育有关的基因。 TCR下游功能或该功能“微调” TCR信号的信号分子。 我们使用TCR-ITAM突变小鼠的结果表明,其他信号分子可以补偿TCR信号强度的降低。对候选补偿性分子的最初基于FACS的搜索使我们进入了CD5,CD5是一种抑制TCR信号传导的TCR相关的跨膜蛋白。重要的是,我们发现CD5表面表达受到TCR信号强度的调节。因此,CD5不简单地充当共受体,而是在胸腺细胞选择过程中对微调TCR信号起作用,因为其表面表达水平取决于TCR信号传导的强度。 TCR信号响应的这种微调的一个明显好处是,可以使具有最大可能多样性的T细胞库生成,因为它可以使更广泛的TCR通过正选择的信号传递窗口。 由于对CD5如何调节TCR信号传导知之甚少,因此我们启动了一个项目来表征CD5功能,无论是在遗传和生化上。这些实验的结果表明了CD5介导的TCR信号抑制的机制,我们目前正在实验测试。我们还开始使用基于微阵列的屏幕来搜索其他调整分子。这种分子的鉴定可能对人类自身免疫性疾病的诊断和治疗可能具有重要意义。在另一项研究中,我们确定了一种新型的T-linege受限推定适配器蛋白,该蛋白被指定为themis。生化研究表明,TRES在TCR信号通路中的远端发挥作用,并且可能具有重要作用是有助于维持TCR信号传导。已经产生了主题 - / - 小鼠,它们的表型揭示了该蛋白质在晚期胸腺细胞发育和选择中的重要作用。当前和投影实验旨在阐明Themis在T细胞信号传导和发育中起作用的机制。 控制造血干细胞规格和维持的基因。 造血系统由功能多样的细胞组成,该细胞源自能够长期自我更新和多条形分化的常见造血干细胞(HSC)。自我更新确保HSC库持续一生,而分化导致所有循环血细胞的连续产生,包括淋巴细胞,髓样细胞,红细胞和血小板。我们启动了旨在识别对HSC生成和维护重要的基因的实验。我们的初步研究集中于LIM结构域结合蛋白-1(LDB1)在造血中的作用。这些实验的结果揭示了LDB1在调节造血干细胞中自我更新/分化细胞命运决策方面具有关键功能,并表明LDB1成核转录复合物可以控制维持谱系特定干细胞的维持。与此相一致,全基因组芯片屏幕鉴定出启动子/基因体内的LDB1结合位点,这些基因的较高基因已知对于HSC维持至关重要。 LDB1的缺失也导致这些基因的表达降低,这表明LDB1复合物是调节HSC维护/自我更新的转录程序的“主调节器”。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PAUL E LOVE其他文献

PAUL E LOVE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PAUL E LOVE', 18)}}的其他基金

Genetic Analysis Of Thymocyte Development
胸腺细胞发育的遗传分析
  • 批准号:
    6541226
  • 财政年份:
  • 资助金额:
    $ 124.07万
  • 项目类别:
Genetic Analysis Of Thymocyte Development
胸腺细胞发育的遗传分析
  • 批准号:
    6813782
  • 财政年份:
  • 资助金额:
    $ 124.07万
  • 项目类别:
Genes and signals controlling mammalian hematopoiesis.
控制哺乳动物造血的基因和信号。
  • 批准号:
    9150094
  • 财政年份:
  • 资助金额:
    $ 124.07万
  • 项目类别:
Genes and signals controlling mammalian hematopoiesis.
控制哺乳动物造血的基因和信号。
  • 批准号:
    10908166
  • 财政年份:
  • 资助金额:
    $ 124.07万
  • 项目类别:
Genes and signals controlling mammalian hematopoiesis.
控制哺乳动物造血的基因和信号。
  • 批准号:
    10007492
  • 财政年份:
  • 资助金额:
    $ 124.07万
  • 项目类别:
Genes and signals controlling mammalian hematopoiesis.
控制哺乳动物造血的基因和信号。
  • 批准号:
    9348228
  • 财政年份:
  • 资助金额:
    $ 124.07万
  • 项目类别:
GENETIC ANALYSIS OF THYMOCYTE DEVELOPMENT
胸腺细胞发育的遗传分析
  • 批准号:
    6432580
  • 财政年份:
  • 资助金额:
    $ 124.07万
  • 项目类别:
Signals Regulating T Cell Development
调节 T 细胞发育的信号
  • 批准号:
    7334053
  • 财政年份:
  • 资助金额:
    $ 124.07万
  • 项目类别:
Genes and signals controlling mammalian hematopoiesis.
控制哺乳动物造血的基因和信号。
  • 批准号:
    8941472
  • 财政年份:
  • 资助金额:
    $ 124.07万
  • 项目类别:
Genetic Analysis Of Thymocyte Development
胸腺细胞发育的遗传分析
  • 批准号:
    6671886
  • 财政年份:
  • 资助金额:
    $ 124.07万
  • 项目类别:

相似国自然基金

嵌合抗原受体巨噬细胞(CAR-M)微马达的制备及其血管蜂窝网络磁驱行为机理与控制方法研究
  • 批准号:
    52375565
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
体内构建嵌合抗原受体Kupffer细胞(CAR-KC)并借助“细胞变装”策略实现肝癌双靶杀伤
  • 批准号:
    82304398
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
脂质纳米粒体内介导嵌合抗原受体-M1型巨噬细胞协同TLR激动剂治疗实体瘤的研究
  • 批准号:
    82304418
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The role of SH2B3 in regulating CD8 T cells in Type 1 Diabetes
SH2B3 在 1 型糖尿病中调节 CD8 T 细胞的作用
  • 批准号:
    10574346
  • 财政年份:
    2023
  • 资助金额:
    $ 124.07万
  • 项目类别:
Microglia-neuron interactions Roles for microglial Iba1
小胶质细胞-神经元相互作用 小胶质细胞 Iba1 的作用
  • 批准号:
    10157121
  • 财政年份:
    2020
  • 资助金额:
    $ 124.07万
  • 项目类别:
Microglia-neuron interactions Roles for microglial Iba1
小胶质细胞-神经元相互作用 小胶质细胞 Iba1 的作用
  • 批准号:
    10310518
  • 财政年份:
    2020
  • 资助金额:
    $ 124.07万
  • 项目类别:
The Role of the Adaptor Protein SH2B3 in Type 1 Diabetes
接头蛋白 SH2B3 在 1 型糖尿病中的作用
  • 批准号:
    10241937
  • 财政年份:
    2018
  • 资助金额:
    $ 124.07万
  • 项目类别:
The Role of the Adaptor Protein SH2B3 in Type 1 Diabetes
接头蛋白 SH2B3 在 1 型糖尿病中的作用
  • 批准号:
    10458084
  • 财政年份:
    2018
  • 资助金额:
    $ 124.07万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了